What does a Hemoglobin A1C (HbA1C) result indicate in terms of diabetes or prediabetes diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HbA1c Diagnostic Thresholds for Diabetes and Prediabetes

An HbA1c of ≥6.5% (≥48 mmol/mol) indicates diabetes, while values between 5.7-6.4% (39-46 mmol/mol) indicate prediabetes or high risk for developing diabetes. 1

Diagnostic Categories

The American Diabetes Association establishes clear HbA1c thresholds using NGSP-certified laboratory methods 1:

  • Normal: <5.7% (<39 mmol/mol) 1
  • Prediabetes: 5.7-6.4% (39-46 mmol/mol) 1
  • Diabetes: ≥6.5% (≥48 mmol/mol) 1

The normal reference interval for HbA1c centers around a mean of 5% (31 mmol/mol), typically ranging from 4.5-5.6% 1. Many laboratories have lowered the upper limit of the reference interval to 5.6% 1.

Prediabetes Risk Stratification

Not all prediabetes values carry equal risk—the relationship between HbA1c and diabetes progression is a continuum with disproportionately greater risk at higher values. 1, 2

  • HbA1c 5.7-6.0%: 5-year diabetes incidence of 9-25%, representing 3-8 fold higher risk than the general population 1
  • HbA1c 6.0-6.4%: 5-year diabetes incidence of 25-50%, with relative risk 20 times higher compared to HbA1c of 5.0% 1, 2

Individuals with HbA1c >6.0% should be considered at very high risk and warrant the most intensive interventions and vigilant follow-up 1, 2.

Confirmation Requirements

For diabetes diagnosis, confirmation with a second HbA1c test on a different sample or a glucose-based test is recommended. 1, 3

Testing must be performed using an NGSP-certified method in an accredited laboratory 1, 2. Point-of-care HbA1c devices should be restricted to FDA-approved devices at CLIA-certified laboratories performing moderate complexity testing or higher, and should not be used for initial diagnosis 1.

Clinical Advantages of HbA1c Testing

HbA1c reflects average glucose levels over the preceding 60-90 days based on the 120-day lifespan of red blood cells 1, 3. The test offers several technical advantages over glucose-based testing 1, 3:

  • Greater preanalytical stability (no fasting required)
  • Lower biological variability
  • No need for glucose loading
  • Increased patient convenience and adherence

Important Caveats and Limitations

Laboratories must be aware of potential interferences that can affect HbA1c results depending on the assay method used. 1

Conditions that can interfere with HbA1c measurements include 4:

  • Anemia
  • Hemoglobinopathies (hemoglobin variants)
  • Uremia
  • Red blood cell destruction

Laboratories should verify by repeat testing any specimens with HbA1c results below the lower limit of the reference interval or greater than 15% 1. Results less than 4% or greater than 15% should prompt investigation for hemoglobin variants 1.

Small changes in HbA1c (±0.3%) over time may reflect assay variability rather than true changes in glycemic status 1.

Sensitivity Limitations for Prediabetes

While HbA1c performs well for diabetes diagnosis, it has modest sensitivity for identifying prediabetes and will miss a substantial proportion of individuals with impaired fasting glucose or impaired glucose tolerance. 5, 6

Research demonstrates that HbA1c 5.7-6.4% alone identifies only 28.5-65.3% of patients with glucose-defined prediabetes 5. The combination of both HbA1c and fasting plasma glucose testing identifies individuals at highest risk for progression to diabetes more effectively than either test alone 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prediabetes Management and Diagnostic Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Severely Uncontrolled Diabetes with HbA1c of 14%

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.